CELADON PHARMACEUTICALS LIMITED

• ⚠

  Annual accounts overdue

  Due 2025-06-30.

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.

1. CELADON PHARMACEUTICALS LIMITED 2025-08-14 → present
2. CELADON PHARMACEUTICALS PLC 2022-03-25 → 2025-08-14
3. SUMMERWAY CAPITAL PLC 2018-08-31 → 2022-03-25

Accounting basis

IFRS

Reporting scope

Consolidated group

Auditor

RSM UK Audit LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Now that the Group has commenced products sales and has access to the £7.0m Revolving Credit Facility and further to the issuance of £5.1m of equity between October 2023 and May 2024, the Directors consider that the Group is able to meet its financial liabilities as they fall due for the period of at least 12 months from the date of this report.”

Group structure

1. CELADON PHARMACEUTICALS LIMITED · parent
   1. Celadon Subco Limited 100% · UK · equity incentive company
   2. Celadon Property Co. Limited 100% · UK · property holding company of the Group and holds the 25 year lease on the Group's 100,000 square foot facility, and following a group reorganization holds the assets relating to the CANPAIN Trial previously held by Harley Street (CPC) Limited.
   3. Celadon Pharma Limited 100% · UK · operating company growing the medicinal cannabis.
   4. Celadon Pharmaceuticals (UK) Limited 100% · UK · dormant company.
   5. Harley Street (CPC) Limited 100% · UK · operates a CQC registered clinic. The assets relating to the CANPAIN Trial were transferred to Celadon Property Co Limited during the year to 31 December 2022.

Significant events

• “On 8 March 2024, the Group disposed of its investment in Harley Street (CPC) Limited for a consideration of £500,000 payable over three years. At the time of the disposal, the only activity conducted by Harley Street (CPC) Limited was the operation of a CQC registered clinic. The assets relating to the CANPAIN Trial had been transferred to Celadon Property Co Limited during 2023.”
• “On 11 April 2024, the Group extended the maturity date of its £7.0 m Revolving Credit Facility to 30 November 2025.”
• “On 10 May 2024, the Group raised £2.1m of additional equity, through the issuance of 2,000,000 ordinary shares of 1p each at a subscription price of £1.05 per share.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

20

last 12 months

Capital events

2

last 24 months

Officers appointed

2

last 12 months

Officers resigned

2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.